Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C968
http://purl.obolibrary.org/obo/NCIT_C968
|
|---|---|
| Preferred Name | Dezaguanine |
| Definitions |
A purine nucleoside analogue with antineoplastic and antiviral activities. By replacing guanine, dezaguanine incorporates into DNA and inhibits de novo purine synthesis, thereby inducing cell death. (NCI)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A purine nucleoside analogue with antineoplastic and antiviral activities. By replacing guanine, dezaguanine incorporates into DNA and inhibits de novo purine synthesis, thereby inducing cell death. (NCI) |
|---|---|
| prefLabel | Dezaguanine
|
| label | Dezaguanine
|
| Has_Salt_Form | |
| PDQ_Closed_Trial_Search_ID | 40086
|
| code | C968
|
| prefixIRI | NCIT:C968
|
| in_subset | |
| Preferred_Name | Dezaguanine
|
| FDA_UNII_Code | 9DRB973HUI
|
| Contributing_Source | FDA
|
| Chemical_Formula | C6H6N4O
|
| Maps_To | Dezaguanine
|
| CAS_Registry | 41729-52-6
|
| NSC Number | 261726
|
| NCI_Drug_Dictionary_ID | 40086
|
| Legacy Concept Name | Dezaguanine
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 40086
|
| Semantic_Type |
Pharmacologic Substance
Nucleic Acid, Nucleoside, or Nucleotide
|
| UMLS_CUI | C0047332
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |